David Starks

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon et al. · Journal of Clinical Oncology · 2023 · 272 citations · Full text

An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)

Amanda N. Fader, David Starks, Paola A. Gehrig et al. · Gynecologic Oncology · 2009 · 121 citations

Tumoral Pathology, Gynecological Surgery, Cervical Cancer +5

Single-port risk-reducing salpingo-oophorectomy with and without hysterectomy: Surgical outcomes and learning curve analysis

Pedro F. Escobar, David Starks, Amanda N. Fader et al. · Gynecologic Oncology · 2010 · 95 citations

Curve Analysis, Gynecologic Surgery, Laparoscopy +8

Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients

Amanda N. Fader, Vivian von Gruenigen, Heidi Gibbons et al. · Gynecologic Oncology · 2008 · 46 citations

Medicine, Cancer Management, Pharmacology +10

Chemokine Analogues Show Suitable Stability for Development as Microbicides

Fabrice Cerini, Alan Landay, Carolyne Gichinga et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2008 · 32 citations

Combinatorial Chemistry, Nanomedicine, Medicinal Chemistry +14